The art and science of switching antipsychotic medications, part 2.

Peter J. Weiden, Alexander L. Miller, Tim J. Lambert, Peter F. Buckley

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

In the presentation "Switching and Metabolic Syndrome," Weiden summarizes reasons to switch antipsychotics, highlighting weight gain and other metabolic adverse events as recent treatment targets. In "Texas Medication Algorithm Project (TMAP)," Miller reviews the TMAP study design, discusses results related to the algorithm versus treatment as usual, and concludes with the implications of the study. Lambert's presentation, "Dosing and Titration Strategies to Optimize Patient Outcome When Switching Antipsychotic Therapy," reviews the decision-making process when switching patients' medication, addresses dosing and titration strategies to effectively transition between medications, and examines other factors to consider when switching pharmacotherapy.

Original languageEnglish (US)
JournalThe Journal of clinical psychiatry
Volume68
Issue number1
StatePublished - Jan 1 2007

Fingerprint

Art
Antipsychotic Agents
Weight Gain
Decision Making
Therapeutics
Drug Therapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Weiden, P. J., Miller, A. L., Lambert, T. J., & Buckley, P. F. (2007). The art and science of switching antipsychotic medications, part 2. The Journal of clinical psychiatry, 68(1).

The art and science of switching antipsychotic medications, part 2. / Weiden, Peter J.; Miller, Alexander L.; Lambert, Tim J.; Buckley, Peter F.

In: The Journal of clinical psychiatry, Vol. 68, No. 1, 01.01.2007.

Research output: Contribution to journalArticle

Weiden, PJ, Miller, AL, Lambert, TJ & Buckley, PF 2007, 'The art and science of switching antipsychotic medications, part 2.', The Journal of clinical psychiatry, vol. 68, no. 1.
Weiden, Peter J. ; Miller, Alexander L. ; Lambert, Tim J. ; Buckley, Peter F. / The art and science of switching antipsychotic medications, part 2. In: The Journal of clinical psychiatry. 2007 ; Vol. 68, No. 1.
@article{eba99388396342e9b43a3d2c9ddc6894,
title = "The art and science of switching antipsychotic medications, part 2.",
abstract = "In the presentation {"}Switching and Metabolic Syndrome,{"} Weiden summarizes reasons to switch antipsychotics, highlighting weight gain and other metabolic adverse events as recent treatment targets. In {"}Texas Medication Algorithm Project (TMAP),{"} Miller reviews the TMAP study design, discusses results related to the algorithm versus treatment as usual, and concludes with the implications of the study. Lambert's presentation, {"}Dosing and Titration Strategies to Optimize Patient Outcome When Switching Antipsychotic Therapy,{"} reviews the decision-making process when switching patients' medication, addresses dosing and titration strategies to effectively transition between medications, and examines other factors to consider when switching pharmacotherapy.",
author = "Weiden, {Peter J.} and Miller, {Alexander L.} and Lambert, {Tim J.} and Buckley, {Peter F.}",
year = "2007",
month = "1",
day = "1",
language = "English (US)",
volume = "68",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "1",

}

TY - JOUR

T1 - The art and science of switching antipsychotic medications, part 2.

AU - Weiden, Peter J.

AU - Miller, Alexander L.

AU - Lambert, Tim J.

AU - Buckley, Peter F.

PY - 2007/1/1

Y1 - 2007/1/1

N2 - In the presentation "Switching and Metabolic Syndrome," Weiden summarizes reasons to switch antipsychotics, highlighting weight gain and other metabolic adverse events as recent treatment targets. In "Texas Medication Algorithm Project (TMAP)," Miller reviews the TMAP study design, discusses results related to the algorithm versus treatment as usual, and concludes with the implications of the study. Lambert's presentation, "Dosing and Titration Strategies to Optimize Patient Outcome When Switching Antipsychotic Therapy," reviews the decision-making process when switching patients' medication, addresses dosing and titration strategies to effectively transition between medications, and examines other factors to consider when switching pharmacotherapy.

AB - In the presentation "Switching and Metabolic Syndrome," Weiden summarizes reasons to switch antipsychotics, highlighting weight gain and other metabolic adverse events as recent treatment targets. In "Texas Medication Algorithm Project (TMAP)," Miller reviews the TMAP study design, discusses results related to the algorithm versus treatment as usual, and concludes with the implications of the study. Lambert's presentation, "Dosing and Titration Strategies to Optimize Patient Outcome When Switching Antipsychotic Therapy," reviews the decision-making process when switching patients' medication, addresses dosing and titration strategies to effectively transition between medications, and examines other factors to consider when switching pharmacotherapy.

UR - http://www.scopus.com/inward/record.url?scp=33847011819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847011819&partnerID=8YFLogxK

M3 - Article

VL - 68

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 1

ER -